PRS37 - Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey
Autor: | Demir, O, Tetik, E, Kamaci, E, Cheynel, J |
---|---|
Zdroj: | In Value in Health October-November 2017 20(9):A646-A646 |
Databáze: | ScienceDirect |
Externí odkaz: |